© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
July 29, 2021
Use of a drug to correct the eyelid position could eliminate the complications associated with surgery.
July 28, 2021
Investigators uncovered evidence that CaMKII could prove to be a desirable therapeutic target for vision preservation in conditions that damage the axons and somas of retinal ganglion cells.
July 28, 2021
Investigators have found that optical coherence tomography findings could prove to be a diagnostic tool for COVID-19.
July 27, 2021
A team of investigators used corneal confocal microscopy to identify corneal nerve damage in cases of long COVID.
July 23, 2021
Jag Dosanjh, senior vice president of U.S. Eye Care, Allergan, an AbbVie company, offers a preview of the company's latest innovations, developments, and what attendees can look forward to at ASCRS 2021.
July 23, 2021
This announcement was made at the 2021 ASCRS annual meeting.
July 23, 2021
A new report has found that glaucoma specialists’ procedure of choice has changed as a result of the COVID-19 pandemic.
July 19, 2021
AAO, Surgical Care Coalition teaming up to ensure the final version of the rule is fair to ophthalmologists and surgeons as one company is expressing its disappointment in the proposal.
July 19, 2021
Nanoscope Therapeutics Inc. has dosed its first patient in a late-stage Phase 2b trial of a gene therapy that delivers multi-characteristic opsin to retinal cells.
July 15, 2021
The Gilbert Family Foundation is collaborating with the Children’s Oncology Group and Children’s Hospital of Philadelphia to validate a tool to measure progressive vision loss.
